以下文章来源于36氪汽车 ，作者李安琪 36氪汽车 . 看懂汽车产业新百年。36氪旗下智能电动车产业报道公号。 成为华为智能辅助驾驶最便宜的 合作车型之一。 文 ｜ 李安琪 编辑 ｜ 李勤 杨轩 来源｜ 36氪汽车（ID：EV36kr） 封面来源 ｜ 官方 36氪汽车独家获悉，上汽通用五菱旗下的宝骏品牌计划推出一款全新车型，该车将搭载华为ADS高阶智能驾驶方案。 有行业人士向36氪透露，新车为SUV车型，配备激光雷达，最快将于年底上市，售价区间大约在 15万-25万元。届时，这将成为 宝骏品牌价格最高的车型。 另一方面，这也是华为与赛力斯、奇瑞、北汽、东风、江淮、上汽、长安、阿维塔、奥迪等10余家国内外车企合作之后，吸纳的 又一车企合作对象。 而宝骏这款新车型，可能成为最便宜的、带有激光雷达的华为智能辅助驾驶合作车型之一。 对此，36氪汽车向宝骏官方进行求证。截至发稿，宝骏官方没有回应。 宝骏是上汽通用五菱旗下的一个品牌，与五菱汽车是兄弟品牌。为甩开五菱"廉价"的标签，2010年上汽通用五菱成立了宝骏品 牌，市场定位与产品定价都高于五菱。凭借宝骏510、730等车型，宝骏2017年曾实现百万年销量。然而，智能 ...

Market Overview - The market is currently experiencing narrow fluctuations and remains in a state of consolidation [1][24] - Major U.S. stock indices rebounded significantly, with the Dow Jones up 2.66%, S&P 500 up 2.51%, and Nasdaq up 2.71%, marking the largest single-day gains in recent weeks [3] Economic Forecasts - The International Monetary Fund (IMF) has significantly downgraded global economic growth forecasts, predicting a decline to 2.8% in 2025 and 3% in 2026, down from earlier estimates of 3.3% for both years [4] - The U.S. economic growth forecast for 2025 has been reduced to 1.8%, with a 40% probability of recession, up from 27% previously [4] Corporate Developments - Baidu released an AI white paper and action plan focusing on generative AI patent layout [9] - Boeing agreed to sell part of its digital aviation solutions business to Thoma Bravo for $10.55 billion [7] - Gree Electric's shareholders approved the re-election of Dong Mingzhu as chairman, with a dividend plan of 10 yuan per 10 shares [12] - Meituan's self-developed fourth-generation drone received a nationwide operational certificate for low-altitude logistics [13] Financial Performance - Newye Semiconductor reported a 384.54% increase in net profit for Q1 2025, with revenue of 4.052 billion yuan, up 264.13% [20] - Hailanxin's Q1 2025 net profit surged by 1324.75%, driven by project completions [21] - Zhonghong Medical's Q1 2025 net profit increased by 1370% [22] - Erkang Pharmaceutical reported a net profit of 28.11 million yuan for Q1 2025, up 868.91% [23] Industry Trends - The pharmaceutical sector is expected to continue its upward trend due to improved fundamentals and technological advancements [24]